Dexamethasone prophylaxis in pediatric open heart surgery is associated with increased blood long pentraxin PTX3:

Franco Lerzo1, Giuseppe Peri, Andrea Doni

  • 1Division of Cardiovascular Surgery, G. Gaslini Institute, IRCCS, Largo G. Gaslini 5, 16148 Genoa, Italy.

Insights

Dexamethasone before heart surgery significantly increased PTX3 levels in children undergoing cardiopulmonary bypass. This suggests PTX3 may play a protective role in reducing inflammation and improving outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Pediatric Cardiology
  • Inflammation and Immunology

Background:

  • Glucocorticoids (dexamethasone) before cardiopulmonary bypass (CPB) may mitigate the systemic inflammatory response.
  • Long pentraxin PTX3 is a novel inflammatory marker with potential protective cardiovascular roles.

Purpose of the Study:

  • To investigate the effect of dexamethasone prophylaxis on PTX3 levels in pediatric patients undergoing CPB.
  • To evaluate the relationship between dexamethasone, PTX3, and other inflammatory markers (CRP, IL-1RII) during pediatric cardiac surgery.

Main Methods:

  • A study of 29 children undergoing open heart surgery with CPB.
  • Fourteen children received dexamethasone prophylaxis, while 15 served as controls.
  • Blood levels of PTX3, CRP, IL-1RII, fibrinogen, and PTT were measured at various time points.

Main Results:

  • PTX3 levels significantly increased during CPB in both groups, but were higher in the dexamethasone group (+D).
  • C-reactive protein (CRP) levels were significantly higher in the control group (-D) postoperatively.
  • Fibrinogen and partial thromboplastin time (PTT) were also higher in the -D group on postoperative day 1.

Conclusions:

  • Dexamethasone prophylaxis in pediatric CPB is associated with increased blood PTX3 levels.
  • Elevated PTX3 may contribute to reduced inflammatory markers and improved clinical outcomes in these patients.

Related Concept Videos

Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Cardiomyopathy VII: Pre and Post Operative Nursing Management01:28

Cardiomyopathy VII: Pre and Post Operative Nursing Management

Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...